Motaz H. Ashkar, M.B.B.S., M.S.

  1. Gastroenterologist
  1. Ashkar M, Chandra S, Vege SS, Takahashi H, Takahashi N, McWilliams RR. Pancreatic involvement due to immune checkpoint inhibitors: a proposed classification. Cancer Immunol Immunother. 2023 Apr; 72 (4):895-901 Epub 2022 Sept 26
    View PubMed
  2. Patel V, Shah P, Ludwig DR, Hammill CW, Ashkar M. Development of de novo nonalcoholic fatty liver disease following pancreatectomy. Medicine (Baltimore). 2023 Jan 27; 102 (4):e32782
    View PubMed
  3. Shah P, Patel V, Ashkar M. De novo non-alcoholic fatty liver disease after pancreatectomy: A systematic review. World J Clin Cases. 2022 Dec 16; 10 (35):12946-12958
    View PubMed
  4. Ashkar MH, Chen J, Shy C, Crippin JS, Chen CH, Sayuk GS, Davidson NO. Increased Risk of Advanced Colonic Adenomas and Timing of Surveillance Colonoscopy Following Solid Organ Transplantation. Dig Dis Sci. 2022 May; 67 (5):1858-1868 Epub 2021 May 10
    View PubMed
  5. Alhobayb T, Peravali R, Ashkar M. The Relationship between Acute and Chronic Pancreatitis with Pancreatic Adenocarcinoma: Review. Diseases. 2021 Dec 20; 9 (4)
    View PubMed
  6. Ashkar M, Gardner TB. Role of endoscopic ultrasound in pancreatic diseases: a systematic review. Minerva Gastroenterol Dietol. 2014 Dec; 60 (4):227-45 Epub 2014 Oct 07
    View PubMed
  7. Susantitaphong P, Altamimi S, Ashkar M, Balk EM, Stel VS, Wright S, Jaber BL. GFR at initiation of dialysis and mortality in CKD: a meta-analysis. Am J Kidney Dis. 2012 Jun; 59 (6):829-40 Epub 2012 Apr 01
    View PubMed